Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 1
1990 1
1991 1
1992 1
1993 1
1995 2
1996 2
1998 2
1999 1
2000 1
2001 2
2002 2
2003 2
2004 1
2005 3
2006 3
2007 6
2008 4
2009 4
2010 5
2011 3
2012 5
2013 6
2014 4
2015 7
2016 4
2017 4
2018 7
2019 6
2020 3
2021 6
2022 8
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 25605552

101 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of oral chelators in treatment of patients with Wilson disease.
Weiss KH, Thurik F, Gotthardt DN, Schäfer M, Teufel U, Wiegand F, Merle U, Ferenci-Foerster D, Maieron A, Stauber R, Zoller H, Schmidt HH, Reuner U, Hefter H, Trocello JM, Houwen RH, Ferenci P, Stremmel W; EUROWILSON Consortium. Weiss KH, et al. Clin Gastroenterol Hepatol. 2013 Aug;11(8):1028-35.e1-2. doi: 10.1016/j.cgh.2013.03.012. Epub 2013 Mar 28. Clin Gastroenterol Hepatol. 2013. PMID: 23542331
Wilson's disease.
Walshe JM. Walshe JM. Lancet. 2007 Mar 17;369(9565):902. doi: 10.1016/S0140-6736(07)60438-3. Lancet. 2007. PMID: 17368141 No abstract available.
Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial.
Schilsky ML, Czlonkowska A, Zuin M, Cassiman D, Twardowschy C, Poujois A, Gondim FAA, Denk G, Cury RG, Ott P, Moore J, Ala A, D'Inca R, Couchonnal-Bedoya E, D'Hollander K, Dubois N, Kamlin COF, Weiss KH; CHELATE trial investigators. Schilsky ML, et al. Lancet Gastroenterol Hepatol. 2022 Dec;7(12):1092-1102. doi: 10.1016/S2468-1253(22)00270-9. Epub 2022 Sep 30. Lancet Gastroenterol Hepatol. 2022. PMID: 36183738 Clinical Trial.
Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease.
Brewer GJ, Askari F, Lorincz MT, Carlson M, Schilsky M, Kluin KJ, Hedera P, Moretti P, Fink JK, Tankanow R, Dick RB, Sitterly J. Brewer GJ, et al. Arch Neurol. 2006 Apr;63(4):521-7. doi: 10.1001/archneur.63.4.521. Arch Neurol. 2006. PMID: 16606763 Clinical Trial.
[Diagnosis and treatment of Wilson disease in Japan].
Shimizu N. Shimizu N. Rinsho Shinkeigaku. 2019 Sep 25;59(9):565-569. doi: 10.5692/clinicalneurol.cn-001241. Epub 2019 Aug 30. Rinsho Shinkeigaku. 2019. PMID: 31474637 Review. Japanese.
101 results